Justice Kavanaugh’s dissent in Harrington v. Purdue Pharma L.P. expresses deep concern for the victims of the opioid crisis and their families. He criticizes the Court’s decision, which he believes will have devastating effects on over 100,000 opioid victims and their families. Kavanaugh emphasizes the need for non-debtor releases to provide relief and funding for communities affected by the crisis.
He argues that without these releases, it is unlikely that any victims or governments will receive compensation. Kavanaugh predicts that the decision will have far-reaching consequences for future victims of mass torts and calls on Congress to address the chaos that will ensue.
He also highlights the bipartisan support for the plan, with all 50 states, thousands of victims, and various government entities endorsing it. Kavanaugh’s dissent is detailed, with a table of contents outlining his arguments in depth.
He discusses the appropriateness of non-debtor releases in mass-tort bankruptcies, defends their use in the Purdue Pharma case, and responds to the Court’s arguments against them. His dissent is comprehensive and thorough.
Overall, Kavanaugh’s dissent in Harrington v. Purdue Pharma L.P. sheds light on the complex legal and moral issues at play in the case, emphasizing the need for justice and relief for the victims of the opioid crisis.
